Kathleen G. Halka

Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

Amit Nathwani, Ulreke M. Reiss, Edward G. D. Tuddenham et al. · New England Journal of Medicine · 2014 · 1.2K citations · Full text

Adeno-Associated Mediated Gene Transfer for Hemophilia B:8 Year Follow up and Impact of Removing "Empty Viral Particles" on Safety and Efficacy of Gene Transfer

Amit C. Nathwani, Ulrike M. Reiss, Edward G. D. Tuddenham et al. · Blood · 2018 · 112 citations

Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome

Maro Ohanian, Christian Cable, Kathleen G. Halka · Clinical Pharmacology Advances and Applications · 2011 · 59 citations · Full text

Hemodialysis, Urology, Medicine +13

Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B

Ulrike M. Reiss, Andrew M. Davidoff, Edward G. D. Tuddenham et al. · New England Journal of Medicine · 2025 · 25 citations · Full text

A randomized, multicenter, phase (Ph) III study comparing carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (Dex) to LEN and Dex in patients (Pts) with relapsed multiple myeloma (MM).

Philippe Moreau, Antonio Palumbo, A. Keith Stewart et al. · Journal of Clinical Oncology · 2011 · 21 citations

Relapsed Multiple Myeloma, Pathology, Tps225 Background +19